These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37579540)

  • 1. The γδ T cells dual function and crosstalk with intestinal flora in treating colorectal cancer is a promising area of study.
    Lin P; Yan Y; Zhang Z; Dong Q; Yi J; Li Q; Zhang A; Kong X
    Int Immunopharmacol; 2023 Oct; 123():110733. PubMed ID: 37579540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune Effects of γδ T Cells in Colorectal Cancer: A Review.
    Ma R; Yuan D; Guo Y; Yan R; Li K
    Front Immunol; 2020; 11():1600. PubMed ID: 33013819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress of research on γδ T cells in colorectal cancer (Review).
    Pan L; Zhou Y; Kuang Y; Wang C; Wang W; Hu X; Chen X
    Oncol Rep; 2024 Dec; 52(6):. PubMed ID: 39364743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controversial role of γδ T cells in colorectal cancer.
    Yu X; Wang L; Niu Z; Zhu L
    Am J Cancer Res; 2024; 14(4):1482-1500. PubMed ID: 38726287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zoledronate facilitates large-scale ex vivo expansion of functional gammadelta T cells from cancer patients for use in adoptive immunotherapy.
    Kondo M; Sakuta K; Noguchi A; Ariyoshi N; Sato K; Sato S; Sato K; Hosoi A; Nakajima J; Yoshida Y; Shiraishi K; Nakagawa K; Kakimi K
    Cytotherapy; 2008; 10(8):842-56. PubMed ID: 19016372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NKp46-expressing human gut-resident intraepithelial Vδ1 T cell subpopulation exhibits high antitumor activity against colorectal cancer.
    Mikulak J; Oriolo F; Bruni E; Roberto A; Colombo FS; Villa A; Bosticardo M; Bortolomai I; Lo Presti E; Meraviglia S; Dieli F; Vetrano S; Danese S; Della Bella S; Carvello MM; Sacchi M; Cugini G; Colombo G; Klinger M; Spaggiari P; Roncalli M; Prinz I; Ravens S; di Lorenzo B; Marcenaro E; Silva-Santos B; Spinelli A; Mavilio D
    JCI Insight; 2019 Dec; 4(24):. PubMed ID: 31689241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulatory and effector functions of gamma-delta (γδ) T cells and their therapeutic potential in adoptive cellular therapy for cancer.
    Paul S; Lal G
    Int J Cancer; 2016 Sep; 139(5):976-85. PubMed ID: 27012367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of BRM-activated killer cells in adoptive immunotherapy: a pilot study with nine advanced cancer patients.
    Ebina T; Fujimiya Y; Yamaguchi T; Ogama N; Sasaki H; Isono N; Suzuki Y; Katakura R; Tanaka K; Nagata K; Takano S; Tamura K; Uno K; Kishida T
    Biotherapy; 1998; 11(4):241-53. PubMed ID: 9950100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. γδ T cells in cancer immunotherapy.
    Zou C; Zhao P; Xiao Z; Han X; Fu F; Fu L
    Oncotarget; 2017 Jan; 8(5):8900-8909. PubMed ID: 27823972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of intestinal flora-related key genes and therapeutic drugs in colorectal cancer.
    Zhang J; Zhang H; Li F; Song Z; Li Y; Zhao T
    BMC Med Genomics; 2020 Nov; 13(1):172. PubMed ID: 33198757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Human γδ T Cells in Anti-Tumor Immunity and Their Potential for Cancer Immunotherapy.
    Liu Y; Zhang C
    Cells; 2020 May; 9(5):. PubMed ID: 32413966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pro-tumor γδ T Cells in Human Cancer: Polarization, Mechanisms of Action, and Implications for Therapy.
    Chabab G; Barjon C; Bonnefoy N; Lafont V
    Front Immunol; 2020; 11():2186. PubMed ID: 33042132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal Cell Carcinoma-Infiltrating CD3
    Lee HW; Park C; Joung JG; Kang M; Chung YS; Oh WJ; Yeom SY; Park WY; Kim TJ; Seo SI
    Curr Issues Mol Biol; 2021 May; 43(1):226-239. PubMed ID: 34071865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy accelerates immune-senescence and functional impairments of Vδ2
    Bruni E; Cazzetta V; Donadon M; Cimino M; Torzilli G; Spata G; Leonardi G; Dieli F; Mikulak J; Mavilio D
    J Immunother Cancer; 2019 Dec; 7(1):347. PubMed ID: 31829255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Dual Roles of Human γδ T Cells: Anti-Tumor or Tumor-Promoting.
    Li Y; Li G; Zhang J; Wu X; Chen X
    Front Immunol; 2020; 11():619954. PubMed ID: 33664732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell immunoglobulin and ITIM domain, as a potential immune checkpoint target for immunotherapy of colorectal cancer.
    Fathi M; Pustokhina I; Kuznetsov SV; Khayrullin M; Hojjat-Farsangi M; Karpisheh V; Jalili A; Jadidi-Niaragh F
    IUBMB Life; 2021 May; 73(5):726-738. PubMed ID: 33686787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human intestinal Vdelta1+ lymphocytes recognize tumor cells of epithelial origin.
    Maeurer MJ; Martin D; Walter W; Liu K; Zitvogel L; Halusczcak K; Rabinowich H; Duquesnoy R; Storkus W; Lotze MT
    J Exp Med; 1996 Apr; 183(4):1681-96. PubMed ID: 8666926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Function of gamma delta (γδ) T cell in cancer with special emphasis on cervical cancer.
    Patra S; Ghosal S; Shand H; Mondal R; Rath A; Kumar Jana S; Ghorai S
    Hum Immunol; 2023 Dec; 84(12):110724. PubMed ID: 37932183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A close look at current γδ T-cell immunotherapy.
    Ma L; Feng Y; Zhou Z
    Front Immunol; 2023; 14():1140623. PubMed ID: 37063836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gamma Delta T-Cell Based Cancer Immunotherapy: Past-Present-Future.
    Saura-Esteller J; de Jong M; King LA; Ensing E; Winograd B; de Gruijl TD; Parren PWHI; van der Vliet HJ
    Front Immunol; 2022; 13():915837. PubMed ID: 35784326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.